Analysts of IIFL Capital Services forecast USD Revenue/EPS Cagr of 16%/15% over FY23-26. However, with the stock trading at 29x their FY25 P/E, they see the risk-reward as balanced. ADD.
Robust performance expected on all key parameters.
Rupee opens at 82.72 paise compared to the previous close of 82.58 paise
Profitability likely to remain strong.
Company targets to reduce costs by Rs400/t over two years. It expects optimisation in Energy Costs, Logistics cost, and other expenses through Group synergies and efficiency capex.
JFE Steel Corporation is already a 15% shareholder in JSW Steel.
In the reporting quarter, operating revenue increased 30% year over year (YoY) to Rs 16,683 crore.
Analysts of IIFL Capital Services believe CTSH’s muted H2 guidance is a reflection of the near-term macro challenges and lower discretionary spending and corroborates with the commentary from the managements of Indian IT service companies.
Mankind Pharma's board approves the reappointment of Ramesh Juneja as chairman and Rajeev Juneja as vice-chairman and managing director.
The company has allocated 62,74,695 equity shares to anchor investors at an upper price band of Rs 741 per share, as confirmed through its exchange filing.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.